Navigation Links
Aware, Inc. Reports Fourth Quarter and 2011 Financial Results

BEDFORD, Mass., Feb. 14, 2012 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and DSL service assurance products, today reported financial results for its fourth quarter and year ended December 31, 2011.  

Revenue for the fourth quarter of 2011 was $5.9 million, a decrease of 14% compared to $6.8 million in the same quarter last year. Net income for the fourth quarter of 2011 was $959,000, or $0.05 per diluted share. These results compared to net income of $230,000, or $0.01 per diluted share, for the same period a year ago.

For the year ended December 31, 2011, revenue increased 4% to $24.6 million, compared to $23.6 million in 2010.  Net income for the year ended December 31, 2011 was $2.6 million, or $0.12 per diluted share. These results compared to net income of $180,000, or $0.01 per diluted share, for the same period a year ago.

Additional information regarding fourth quarter financial results is presented below:

Product revenue declined from $5.3 million in the fourth quarter of 2010 to $4.2 million this quarter. The decrease was due to lower DSL service assurance hardware and software revenue.  Sales of biometrics software were higher than the year ago quarter, but not enough to offset lower DSL service assurance revenue.

The increase in services revenue from $949,000 in the fourth quarter of 2010 to $1.1 million this quarter was due to increased revenue from biometrics engineering projects.  The increase in royalties from $548,000 in the fourth quarter of 2010 to $605,000 this quarter was due to higher royalties reported to us by one of our DSL chip licensees.

Spending declined from $6.6 million in the fourth quarter of 2010 to $5.0 million this quarter. The $1.6 million spending decrease was primarily the result of three factors: i) lower hardware cost of goods sold on lower hardware sales; ii) lower legal fee spending; and iii) lower officer compensation expenses.

We had 77 full time employees at December 31, 2011, which was down from 81 heads at the end of last quarter.

Rick Moberg, Aware's co-chief executive officer and chief financial officer, said, "Net income of almost $1.0 million this quarter was driven by revenue growth of our biometrics business and lower expenses.  Biometrics software products and services continued to sell well in the fourth quarter. In January 2012 we announced we were going to stop selling DSL hardware products. We intend to continue to sell DSL service assurance software products.  Results for the full year in 2011 were also encouraging. Net income was $2.6 million and we increased our cash and investments by $7.4 million to $47.3 million.  

With respect to our patent management operations, our board is continuing to review its strategic options, including a potential spin-off, sale, or licensing of patents."

About AwareAware is a leading software and technology supplier for the biometrics, telecommunications, and healthcare industries. Aware's biometrics software products and services are provided to solution vendors and system integrators for use by government agencies towards applications including border management, secure credentials, law enforcement, and national defense. Aware's DSL Service Assurance Group offers test and diagnostics software and hardware products that enable broadband service providers to manage their DSL networks. Aware also provides standards-based medical imaging software products to the healthcare industry.  Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

Safe Harbor WarningPortions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings and the growth of the DSL service assurance and biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements.

General factors include, but are not limited to: our quarterly results are unpredictable and may fluctuate significantly; our business is subject to rapid technological change; we face intense competition from a wide range of competitors; our intellectual property is subject to limited protection; our business may be affected by our use of open source software; our business may be affected by government regulations; adverse economic conditions; and our ability to obtain or enforce patents could be affected by new laws, regulations or rules. DSL service assurance factors include, but are not limited to: our DSL service assurance product line depends upon a limited number of customers; our DSL service assurance hardware and software products could have quality problems; we depend on a single source contract manufacturer for the manufacture of our DSL hardware products; and we are dependent on single source suppliers for components in our DSL hardware products. Biometric factors include, but are not limited to: market acceptance of our biometric technologies and products; changes in contracting practices of government or law enforcement agencies; the failure of the biometrics market to experience continued growth; announcements or introductions of new technologies or products by our competitors; failures or problems in our biometric software products; delays in the adoption of new industry biometric standards; growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver services contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones. Further, there can be no assurance as to the timing of a possible transaction with respect to our patent management operations, whether it will ultimately be structured as a spin-off, sale, or license or whether such a transaction will be completed.

We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2010 and other reports and filings made with the Securities and Exchange Commission.

Aware and Dr. DSL are trademarks or registered trademarks of Aware, Inc.

Any other trademarks appearing herein are the property of their respective owners.AWARE, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)Three Months EndedYear EndedDecember 31,December 31, 2011201020112010Revenue:Product sales$4,152$5,326$18,129$18,914Services1,1359494,3111,992Royalties6055472,1462,654Total revenue5,8926,82224,58623,560Costs and expenses:Cost of product sales5521,2503,6374,362Cost of services5563621,777714Research and development1,6391,8987,2408,096Selling and marketing1,2851,1354,4414,283General and administrative9361,9695,0056,438Total costs and expenses4,9686,61422,10023,893Income (loss) from operations9242082,486(333)Other income---425Interest income35228390Income before provision for income taxes9592302,569182Provision for income taxes  --22Net income$959$230$2,567$180Net income per share – basic  $0.05$0.01$0.12$0.01Net income per share – diluted$0.05$0.01$0.12$0.01Weighted average shares – basic20,61220,04020,53419,971Weighted average shares - diluted20,77520,52720,73520,182AWARE, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)December 31,2011December 31,2010ASSETSCash and investments$46,577$39,949Accounts receivable, net 3,5464,968Inventories, net 5471,863Property and equipment, net6,2326,360Investments727-Other assets, net222260Total assets$57,851$53,400LIABILITIES AND STOCKHOLDERS' EQUITYTotal current liabilities$2,814$3,197Long-term deferred revenue462320Total stockholders' equity  54,57549,883Total liabilities and stockholders' equity$57,851$53,400

SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
2. Aware, Inc. Commences Dutch Auction Tender Offer
3. Aware, Inc. Commences Dutch Auction Tender Offer
4. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
5. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
6. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
7. Aware, Inc. Announces Q1 09 Earnings Conference Call
8. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
9. Aware, Inc. Reports First Quarter 2009 Financial Results
10. Aware, Inc. Reports First Quarter 2009 Financial Results
11. Aware, Inc. Announces Q209 Earnings Conference Call
Post Your Comments:
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
(Date:3/20/2017)... PMD Healthcare announces the release of its ... System (WMS), a remote, real-time lung health monitoring and ... is a Medical Device, Digital Health, and Chronic Care ... innovative solutions that empower people to improve their healthcare ... developed the first ever personal spirometer, Spiro PD, which ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  Continue ... ... to match face pictures against each other or against large databases. The recognition ... ... software for biometric Face Matching on the market. The speed is at 100 ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... -- According to a report by Transparency Market Research ... to the presence of a large pool of participants; however, only ... and Sigma-Aldrich, compete with each other in this market. With Proliant ... 76% of this market in 2016.  ... As of now, a large number of vendors ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research ... GSK to generate genetic sequence data from the 500,000 volunteer ... researchers to gain valuable insights to support advances in the ... and life threatening diseases. ... Genetic evidence has revolutionized scientific discovery ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
Breaking Biology Technology: